In a bid to change direction, what had been largely a GREEK generics drugmaker, Pharmathen is now shedding that image. Now based in the Netherlands, Pharmathen, a BC Partners portfolio company, has announced the sale of its GREEK commercial operations as part of its long-term strategy to ...
 |
| READ THE ORIGINAL POST AT www.thepharmaletter.com |
